metformin has been researched along with Muscle Weakness in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of metformin-associated lactic acidosis after elective spinal surgery is reported." | 7.71 | Metformin-associated lactic acidosis after elective cervical spine fusion: a case report. ( Brager, MD; Lipsett, PA; Mears, SC; Riley, LH, 2002) |
| "Metformin is a biguanide antidiabetic drug, with potential to delay aging at cellular and organismal levels." | 6.82 | Targeting Myotonic Dystrophy Type 1 with Metformin. ( García-Puga, M; López de Munain, A; Matheu, A; Saenz-Antoñanzas, A, 2022) |
| "Background: Sepsis is a life-threatening medical emergency, frequently complicated with intensive care unit-acquired weakness syndrome (ICU-AW)." | 5.91 | CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN. ( Chen, J; Chen, XY; Cong, XX; Huang, M; Sun, YT; Wang, S; Xu, SB; Zheng, LL; Zhou, YT, 2023) |
| "A 28-year-old Taiwanese woman presented with dyspnoea, poor appetite, and muscle weakness after using antiobesity drugs, including metformin, triiodothyronine, and topiramate." | 4.02 | Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency. ( Liang, WC; Liao, WA; Lin, PY; Sun, YT, 2021) |
| "A case of metformin-associated lactic acidosis after elective spinal surgery is reported." | 3.71 | Metformin-associated lactic acidosis after elective cervical spine fusion: a case report. ( Brager, MD; Lipsett, PA; Mears, SC; Riley, LH, 2002) |
| "Metformin is a biguanide antidiabetic drug, with potential to delay aging at cellular and organismal levels." | 2.82 | Targeting Myotonic Dystrophy Type 1 with Metformin. ( García-Puga, M; López de Munain, A; Matheu, A; Saenz-Antoñanzas, A, 2022) |
| "Background: Sepsis is a life-threatening medical emergency, frequently complicated with intensive care unit-acquired weakness syndrome (ICU-AW)." | 1.91 | CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN. ( Chen, J; Chen, XY; Cong, XX; Huang, M; Sun, YT; Wang, S; Xu, SB; Zheng, LL; Zhou, YT, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Puga, M | 1 |
| Saenz-Antoñanzas, A | 1 |
| Matheu, A | 1 |
| López de Munain, A | 1 |
| Chen, J | 1 |
| Chen, XY | 1 |
| Cong, XX | 1 |
| Wang, S | 1 |
| Xu, SB | 1 |
| Sun, YT | 2 |
| Zhou, YT | 1 |
| Zheng, LL | 1 |
| Huang, M | 1 |
| Lin, PY | 1 |
| Liang, WC | 1 |
| Liao, WA | 1 |
| Liu, S | 1 |
| Lee, YF | 1 |
| Chou, S | 1 |
| Uno, H | 1 |
| Li, G | 1 |
| Brookes, P | 1 |
| Massett, MP | 1 |
| Wu, Q | 1 |
| Chen, LM | 1 |
| Chang, C | 1 |
| Mears, SC | 1 |
| Lipsett, PA | 1 |
| Brager, MD | 1 |
| Riley, LH | 1 |
1 review available for metformin and Muscle Weakness
| Article | Year |
|---|---|
Targeting Myotonic Dystrophy Type 1 with Metformin.
Topics: Humans; Hypoglycemic Agents; Metformin; Muscle Weakness; Myotonic Dystrophy; Phenotype | 2022 |
4 other studies available for metformin and Muscle Weakness
| Article | Year |
|---|---|
CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN.
Topics: Animals; Cellular Senescence; Lipopolysaccharides; Metformin; Mice; Muscle Weakness; Sepsis; Tumor S | 2023 |
Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
Topics: Adult; Anti-Obesity Agents; Asian People; Carnitine; Female; Humans; Metformin; Multiple Acyl Coenzy | 2021 |
Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; Animals; Cells, Cultured; Electron Transport Com | 2011 |
Metformin-associated lactic acidosis after elective cervical spine fusion: a case report.
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Cervical Vertebrae; Humans; Hypoglycemic Agents; Male; Me | 2002 |